Renold Capocasale

Biography

Renold is the Founder and CEO of FlowMetric, Inc a niche Contract Research Oganization (CRO) established in early 2010 and has over 20 years of experience in pharmaceutical research and development. He is an expert in polychromatic flow cytometry, cell sorting and immunology-based assay development. Prior to establishing FlowMetric, Renold worked for over 13 years at Centocor, a subsidiary of Johnson and Johnson. He established the polychromatic flow facility at Centocor to perform polychromatic flow cytometry and cell sorting. His work at Centocor earned him five prestigious Johnson & Johnson awards for scientific excellence and innovation. He has worked on marketed compounds, Remicade® and Stelara®.  Ren has authored more than 30 peer reviewed scientific manuscripts and publications. He is co-author of one US Patent and has been invited to speak at International Conferences. He has also co-authored a chapter on the “Application of Flow Cytometry in Drug Development” for Immunotoxicology Strategies for Pharmaceutical Safety Assessment, published by John Wiley & Sons in August 2008.In 2013, Renold expanded FlowMetric into Lodi, Italy with the creation of FlowMetric Europe srl and is the Chairman of the Board for FlowMetric Diagnostics.  Renold earned his undergraduate degree from Villanova University. Renold sits on the Board of Trustees of Neumann University and is also a board member of iPraxis, a not-for-profit educational institution focused on science and technology education.  In addition Renold is an Adjunct Professor at Drexel University College of Medicine and is active in the Boy Scouts as an Assistant Scoutmaster.

Research Interest

Life sciences